These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Dopamine autoreceptor agonists in the treatment of schizophrenia and major depression. Benkert O, Gründer G, Wetzel H. Pharmacopsychiatry; 1992 Nov; 25(6):254-60. PubMed ID: 1362997 [Abstract] [Full Text] [Related]
33. Roxindole, a dopamine autoreceptor agonist with a potential antidepressant activity. II. Effects on the 5-hydroxytryptamine system. Maj J, Kołodziejczyk K, Rogóz Z, Skuza G. Pharmacopsychiatry; 1997 Mar; 30(2):55-61. PubMed ID: 9131725 [Abstract] [Full Text] [Related]
35. Endocrine characterization of the new dopamine autoreceptor agonist roxindole. Wiedemann K, Kellner M. Exp Clin Endocrinol; 1994 Mar; 102(4):284-8. PubMed ID: 7813599 [Abstract] [Full Text] [Related]
36. Dopamine autoreceptor agonists in the treatment of schizophrenia and major depression. Benkert O, Gründer G, Wetzel H. Pharmacopsychiatry; 1992 Nov; 25(6):254-60. PubMed ID: 1362997 [Abstract] [Full Text] [Related]
37. Endocrine characterization of the new dopamine autoreceptor agonist roxindole. Wiedemann K, Kellner M. Exp Clin Endocrinol; 1994 Nov; 102(4):284-8. PubMed ID: 7813599 [Abstract] [Full Text] [Related]
38. Dopamine autoreceptor agonists in the treatment of schizophrenia and major depression. Benkert O, Gründer G, Wetzel H. Pharmacopsychiatry; 1992 Nov; 25(6):254-60. PubMed ID: 1362997 [Abstract] [Full Text] [Related] Page: [Previous] [New Search]